Show simple item record

dc.contributor.authorHEPS
dc.date.accessioned2021-12-30T17:00:23Z
dc.date.available2021-12-30T17:00:23Z
dc.date.issued2010
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/955
dc.description.abstractThe MDP 301 microbicide trial used multiple approaches at the Masaka site to mobilise and sensitise the community, get feedback, share information, and communicate the final trial results. While this broad approach contributed to the success of the trial, a survey conducted early 2010 found no evidence that civil society advocacy groups were invited to contribute to the trial’s design and implementation. By outlining the key successes and failures of the trial’s community involvement initiatives, this brief highlights the need for HIV prevention research in general to follow good community participatory practice guidelines by nurturing local advocates from the civil society to partner with the investigators in the conduct of research.en_US
dc.language.isoenen_US
dc.publisherHEPS-Uganda Policy Briefing Seriesen_US
dc.relation.ispartofseries;07
dc.titleCommunity involvement in MDP 301 microbicide trial in Masaka: Successes and failuresen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record